SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Antex Biologics (ANTX) -- Ignore unavailable to you. Want to Upgrade?

To: RIP who wrote (793)3/31/1998 11:37:00 AM
From: Matthew Cooper  Respond to of 1476
 
I am new to this board, but have been following ANTX for a while. Could anyone please bring me up-to-date on the current status of all the Phase I, II and III trials of the products that ANTX is currently testing? Expected dates of completion, etc? Any additional info would also be greatly appreciated. Thank you!



To: RIP who wrote (793)3/31/1998 7:22:00 PM
From: Joseph Wisnowski  Read Replies (1) | Respond to of 1476
 
RIP: I just finished reviewing Pre 14A released by ANTX today at the following site-

freeedgar.com

It says they are to discuss either a 1 for 10 or a 1 for 4 reverse stock split at their meeting on June 8. I have not had good results in stocks I've owned in the past who have had reverse splits Do you feel that this will negatively effect the stock value? Any input would be appreciated. Thanks, Joe


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News